Back to Search Start Over

Prognosis of patients treated for Cushing syndrome.

Authors :
Aulinas A
Valassi E
Webb SM
Source :
Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion [Endocrinol Nutr] 2014 Jan; Vol. 61 (1), pp. 52-61. Date of Electronic Publication: 2013 Jul 03.
Publication Year :
2014

Abstract

Cushing syndrome (CS), due to an ACTH-secreting pituitary adenoma, adrenal tumors, or ectopic ACTH secretion, causes hypercortisolism. CS is associated with major morbidity, especially metabolic and cardiovascular complications, osteoporosis, psychiatric changes, and cognitive impairment. Despite biochemical "cure" of hypercortisolism and clinical improvement after effective treatment, these complications are only partially reversible. Exacerbation of prior autoimmune diseases is also seen. All of these lead to quality of life impairment and increased mortality. This review addresses the main comorbidities and long-term consequences of CS despite clinical and biochemical "cure".<br /> (Copyright © 2013 SEEN. Published by Elsevier Espana. All rights reserved.)

Details

Language :
English; Spanish; Castilian
ISSN :
1579-2021
Volume :
61
Issue :
1
Database :
MEDLINE
Journal :
Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion
Publication Type :
Academic Journal
Accession number :
23831107
Full Text :
https://doi.org/10.1016/j.endonu.2013.03.008